Ardent Health acquiring Missouri nonprofit Boone Health for $47M

Ardent Health is acquiring Boone Health, a Missouri nonprofit, for $47M in cash, with a $200M capital commitment. The deal, expected to close in Q1 2027, expands Ardent's market and is projected to generate $5M-$10M in additional EBITDA in the first year, with $30M in annual synergies after three years. Boone Health has about 30% market share and $500M in annual revenue.

Original reporting
Published Nov 13, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 9:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ARDT
Bullish
medium confidence
Mentioned
$ARDT
Relevance
8/10
AlphAI data visualization · based on fiercehealthcare.com
Decision brief

The 30-second read

$ARDTBullishMed
01

Why it matters

Ardent’s first Missouri entry is structured to preserve Boone’s mission and workforce while funding facility and emergency department expansion, with quantified operating targets to drive value creation.

02

Market read

For traders, the actionable item is the disclosed M&A economics and integration plan for Ardent, including near-term emergency expansion and multi-year synergy targets.

03

What to watch

Regulatory approvals, payer mix changes, and the operational impact of maintaining essential services and charity care could reduce the speed or magnitude of cost and revenue-cycle benefits.

Relevance 8/10Novelty 8/10Timing: deal expected to close in Q1 2027, with investor call coverage on the announcement date

Background

Boone Health has been independent since 2021 after operating within BJC HealthCare for decades; in 2025 it sought strategic partners for capital and growth support.

Company-level read

Ticker impact

$ARDTBullishMedium confidence
Context

Ardent Health agreed to acquire Boone Health for $47M cash, with a 10-year $200M capital commitment and expected EBITDA/synergy targets.

Expected impact

Likely positive bias as investors price in accretion and growth, tempered by uncertainty around integration and realized synergies.

Evidence & confidence

The article discloses concrete deal economics ($47M price, $200M capital commitment) and quantified operating targets ($5M-$10M EBITDA in year one, $30M annual synergies after three years).

Market effects

Signals continued consolidation among regional healthcare providers and increased capital deployment into emergency and referral-center capacity.

Expands Ardent’s Missouri footprint and could intensify competition in Columbia and surrounding referral patterns.

Limited direct global linkage; primarily a US healthcare M&A and regional capacity story.

Counterpoint

Synergy and EBITDA targets may be optimistic given nonprofit-to-for-profit integration frictions, labor constraints, and reimbursement pressure in emergent care.

Key entities

  • Ardent Health

    Agreed to acquire Boone Health for $47M cash and commit $200M over 10 years, targeting EBITDA and synergy improvements.

  • Boone Health

    Mid-sized nonprofit system in Columbia, Missouri, with a 392-bed Boone Hospital Center and about $500M annual revenue.

  • Dave Caspers

    Ardent CEO who discussed the deal rationale and expected financial improvements.

  • Jerry Kennett, M.D.

    Chair of Boone’s Board of Trustees supporting the transaction.

Related articles

$ARDTMed

BofA raises Ardent Health stock price target on acquisition upside

BofA Securities raised its price target on Ardent Health Partners (ARDT) to $14 from $12, citing the company's acquisition of Boone Health. The stock trades at $17.68, near its 52-week high. BofA expects the deal to add $5M-$10M in EBITDA in the first year, growing to $30M-$40M by the third year. Ardent reported Q3 2026 earnings of $0.31 per share, beating estimates. Mizuho also raised its target to $21, maintaining an Outperform rating.

$ARDTMed

What Ardent Health (ARDT) Said on Its Q3 Earnings Call

Ardent Health (ARDT) reported Q3 earnings, highlighting a 9% increase in urgent care visits and a 400 basis point decline in physician referral leakage. Labor costs fell 4.3% YoY, and the company plans to sell a Kansas hospital for 11x EBITDA. Ardent generated $122M in Q3 operating cash flow and lowered its 2026 capital expenditure guidance. The company remains 85% contracted for 2027 and 75% for 2028, with negotiations described as contentious.

$ARDTHighAI 8/10

Ardent Health (ARDT) Q3 2026 Earnings Call Transcript

Ardent Health (ARDT) reported Q3 2026 adjusted EBITDA of $138M, up 1.5% from prior guidance. Revenue was $1.62B, with adjusted admissions up 2.9%. The company plans to divest a Kansas hospital at 11x EBITDA, enhancing margins by 40bps. Ardent's IMPACT program aims for $70M in savings this year, and it raised its EBITDA guidance midpoint by 1.5%.

$ARDTHigh

Ardent Health Reports Third Quarter 2026 Results

Ardent Health, Inc. (ARDT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Exhibit 99.1 Ardent Health Reports Third Quarter 2026 Results Brentwood, Tenn. ( November 4, 2026 ) – Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced re